Phage lytic enzymes: a history

Virologica Sinica

Volumn 30, Issue 1, 2015, Pages 26-32

  Trudil, David ^a  

^a New Horizons Diagnostic Corporation   (United States)

Author keywords

bacteriophage; lysin; phage lytic enzymes; translational application

Indexed keywords

ANTIBIOTIC AGENT; COLLOIDAL GOLD; ENDOLYSIN; ENZYBIOTIC; HYDROLASE; LYSINE; LYSOZYME; MURALYSIN; PHAGE ASSOCIATED ENZYME; PHAGE LYSIN; PHAGE LYSOZYME; PHAGE LYTIC ENZYME; UNCLASSIFIED DRUG; VIROLYSIN; VIRUS ENZYME; VIRUS PROTEIN;

BACILLUS ANTHRACIS; BACTERICIDAL ACTIVITY; BACTERIOLYSIS; BACTERIOPHAGE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BIOLUMINESCENCE; DISINFECTION; HUMAN; NONHUMAN; REVIEW; STREPTOCOCCUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; YERSINIA PESTIS; ENZYMOLOGY; GENETICS; HISTORY; METABOLISM; VIROLOGY;

BACTERIOPHAGES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; VIRAL PROTEINS; VIROLOGY;

EID: 84923125098     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-014-3549-0     Document Type: Review

References (34)

1. Abedon ST. 2011. Bacteriophage prehistory: is or is not Hankin, 1896, a phage reference? Bacteriophage, 1: 174–178.
2. Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. 2011. Phage Treatment of human infections. Bacteriophage, 1: 66–85.
3. Bernstein D, Fischetti VA. 1997. Method for exposing group a streptococcal antigens and an improved diagnostic test for the identification of group a streptococci. US Patent 05604109.
4. Briersa Y, Walmagha M, Van Puyenbroecka V, Cornelissena A, Cenensb W, Aertsenb A, Oliveirac H, Azeredoc J, Verweend G, Pirnayd JP, Miller S, Volckaerta G, Lavignea R. 2014. Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens. MBio, 5: e01379–14.
5. Bruynoghe R, Maisin J. 1921. Essais de thérapeutique au moyen du bactériophage du Staphylocoque. Compt Rend Soc Biol, 85:1120–1121. (In French)
6. Cutter CN, Dorsa WJ, Siragusa GR. 1996. A rapid microbial ATP bioluminescence assay for meat carcasses. Dairy, Food & Environ. San, 16: 726–736.
7. d’Herelle FH. Sur un microbe invisible antagoniste des bacilles dysenteriques.1917. C R Acad Sci Gen, 165: 373–375. (In French)
8. d’Hérelle F. 1931. Bacteriophagy and recovery from infectious disease. Can Med Assoc J. 24: 619–628
9. th Int Workshop on Bioencapsulation. Marison I, Poncelet D, Eds., Dublin, Ireland, pp1–4.
10. Fischetti VA. 2005. Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol, 13: 491–496.
11. Fischetti VA, Gotschlich EC, Bernheimer AW. 1971. Purification and Physical Properties of Group C Streptococcal Phage Associated Lysin. J Exp Med, 133: 1105–1117.
12. Fischetti VA, Loomis L. 1999. Prophylactic and therapeutic treatment of group A streptococcal infection. US Patent 5,985,271 A.
13. Florin P. 2006. Bacterial Contamination in a Field Hospital. Proc CBMTS-VI. Spiez, Switzerland.
14. Hasan JAK, S Garg, L Loomis, D Miller, and RR Colwell. 1997. A rapid surface-monitoring method for bacteria employing ATP bioluminescence. Abstr 97th General Meeting of Am. Soc. Microbiol, abstr I-026.
15. Hankin ME. 1896. L’action bactéricide des eaux de la Jumna et du Gange sur le vibrion du choléra. Ann Inst Pasteur (Paris), 10:511–523. (In French)
16. Harper DR, Kutter E. 2008. Bacteriophage: therapeutic use. Encyclopedia of Life Sciences. Chichester, UK: John Wiley & Sons, Ltd.; pp1–7.
17. Ho K. 2001. Bacteriophage therapy for bacterial infections. Rekindling a memory from the pre-antibiotics era. Perspect Biol Med, 44: 1–16.
18. Hoopes JT, Stark CJ, Kim HA, Sussman DJ, Donovan DM, Nelson DC. 2009. Use of a bacteriophage lysin, PlyC, as an enzyme disinfectant against Streptococcus equi. Appl Environ Microbiol, 75: 1388–1394.
19. Krause RM.1958. Studies on the Bacteriophages of Hemolytic Streptococci. J Exp Med, 108: 803–821.
20. Klyachko NL, Dmitrieva NF, Eshchina AS, Ignatenko OV, Filatova LY, Rainina EI, Kazarov AK, Levashov AV. 2008. Bacteriophage enzyme for the prevention and treatment of bacterial infections: stability and stabilization of the enzyme lysing Streptococcus pyogenes cells. Russ J Bioorganic Chem, 34: 375–379.
21. Maxted WR. 1957. The Active Agent in Nascent Phage Lysis of Streptococci. J Gen Micro, 16: 585–595.
22. Nelson D, Loomis L, Fischetti VA. 2001. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using bacteriophage lytic enzyme, Proc Natl Acad Sci U S A, 98:4107–4112.
23. Roach DR, Khatibi PA, Bischoff KM, Hughes SR and Donovan DM. 2013. Bacteriophage-encoded lytic enzymes control growth of contaminating Lactobacillus found in fuel ethanol fermentations. Biotechnol Biofuels, 6:20.
24. Schmelcher M, Powella A, Beckera S, Campb M, Donovan D. 2012. Chimeric phage lysins act synergistically with lysostaphin to kill mastitis — causing Staphylococcus aureus in murine mammary glands. Appl Environ Microbiol, 78: 2297–2305.
25. Schuch R, Nelso D, Fischetti V. 2002. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature, 418: 884–889.
26. Siragusa GR, Cutter CN, Dorsa WJ, Koohmaraie M. 1995. Use of a rapid microbial ATP bio- luminescence assay to detect contamination on beef and pork carcasses. J Food Prot, 58: 770–775.
27. Siragusa GR, Dorsa WJ, Cutter CN, Perino LJ, Koohmaraie M. 1996. Use of a newly developed rapid microbial ATP bioluminescence assay to detect microbial contamination on poultry carcasses. J Biolumin Chemilumin, 11: 297–301.
28. Stopa PJ, Tieman D, Coon PA, Milton MM, Paterno D. 1999. Detection of biological aerosols by luminescence techniques. Field Anal Chem Technol, 3: 283–290.
29. Sulakvelidze A, Barrow P. 2005. Phage therapy in animals and agribusiness. In: Bacteriophages: Biology and Applications. Kutter E, Sulakvelidze. Boca Raton: CRC Press. pp335–380.
30. Summers WC. 2001. Bacteriophage therapy. Annu Rev Microbiol, 55: 437–451.
31. Trudil D. 2002. Use of phage associated lytic enzymes for rapid detection of bacterial contaminants (priority date 1999). US Patent 6395504.
32. TH SISPAT, Singapore.
33. Twort FW. 1915. An investigation on the nature of ultramicroscopic viruses. Lancet, 186: 1241–1246.
34. Yang H, Zhang Y, Yu J, Huang Y, Zhang XE, Wei H. 2014. Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo. Antimicrob Agents Ch, 58: 536–542.